Beyond Air (XAIR) CEO Robert Goodman Buys 34,722 Shares & Warrants

What Happened

• Robert Scott Goodman, CEO of Beyond Air, acquired 34,722 shares of common stock on 2026-07-29 in an open-market/private purchase. The reported cash value of the transaction was $199,999 (34,722 units at a combined price of $5.76 each).
• The filing also shows Goodman received two related derivative securities (Series A and Series B warrants) in the same unit purchases; the warrants are reported separately with no per-warrant price listed. This is a purchase (insider bought equity and attached warrants), which investors often view as a more informative signal than routine sales, though motivations are not disclosed.

Key Details

• Transaction date: 2026-07-29; Form 4 filed 2026-07-31 (appears timely under the two-business-day rule).
• Purchase: 34,722 common shares at a combined unit price of $5.76; total reported value $199,999.
• Derivatives: 34,722 Series A warrants and 34,722 Series B warrants were acquired together with the shares; warrant prices are reported as N/A.
• Footnotes: F1 — exercisable immediately upon issuance; F2 — expiration is the earlier of (i) one year from issuance or (ii) 45 days after FDA approval of a pending premarket approval supplement for LungFit PH II; F3 — each Series A and Series B warrant was purchased together with one share for the combined $5.76 price; F4 — one instrument expires five years after issuance.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Filing date indicates this was filed promptly (no late-file flag shown).

Context

• The transaction consisted of unit purchases combining one common share with attached warrants (per footnote), rather than a plain market-only buy. Warrant terms (immediate exercisability and differing expiration conditions) mean the derivatives could convert to additional economic exposure if exercised; no exercise or sale of the shares was reported at the time. As always, purchases by insiders are factual data points; they do not prove future performance.